EUVIMEDEUVIMED entdecken
Crossref

Permanent Hypoparathyroidism After Total Thyroidectomy Is Associated With Chronic Kidney Disease

Jessan A Jishu iD, Dara Bruce, Emily Persons, Marcela Herrera, Alexandra LaForteza, Yaser Y Bashumeel, Mohamed A Shama, Moh'd Sharshir, Emad Kandil

The American Surgeon™ · 24.07.2026

DOI: 10.1177/00031348261471480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Surgeon™, online erschienen am 24.07.2026. Verfasst von Jessan A Jishu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tulane University School of Medicine, New Orleans, LA, USA. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Permanent hypoparathyroidism (PHypoPT) is common after total thyroidectomy (TT), yet the persistence and magnitude of renal consequences following this complication have not been characterized in large-scale populations.

Methods

Between January 2004 and December 2024, adult patients who underwent TT were identified from the TriNetX Research Network. Propensity matching was performed on age, demographics, and comorbidities. The primary outcomes were the incidence of CKD and burden of renal impairment; the secondary outcome was mortality. All outcomes were followed over 10 years.

Results

We identified 73,999 patients who underwent TT, of whom 2706 developed subsequent PHypoPT. After matching, there were 2691 patients per cohort. PHypoPT was associated with a significantly increased risk of developing CKD (HR 1.67, 95% CI: 1.39-2.02) with decreased mean estimated glomerular filtration rate (78.5 ± 26.3 mL/min/1.73 m 2 vs 83.1 ± 25.5 mL/min/1.73 m 2 , P < .01). The risk for CKD was increased in both early (HR 2.18, 95% CI: 1.75-2.71) and late (HR 2.75, 95% CI: 1.62-4.69) stages. When stratifying by indication, the increased risk persisted in patients with thyroid cancer (HR 1.70, 95% CI: 1.26-2.30), thyrotoxicosis (HR 2.41, 95% CI: 1.55-3.73), and goiter (HR 2.00, 95% CI: 1.58-2.45). There were no differences in risks for mortality.

Conclusions

PHypoPT after TT for both benign and malignant disease demonstrates an increased risk of CKD with worsening burden over time, indicating that this surgical complication may have systemic consequences that extend beyond postoperative care. Prospective studies should confirm such findings and assess the need for heightened surveillance in affected patients.

Schlagwörter

Stichwörter der Autor:innen

endocrinegeneral surgeryhead/neckrenalsurgical oncology

Autor:innen und Institutionen

  • Tulane University School of Medicine, New Orleans, LA, USA.
  • Louisiana State University Health Sciences Center School of Medicine, New Orleans, LA, USA.
  • Division of Endocrine and Oncological Surgery, Department of Surgery, Tulane University School of Medicine, New Orleans, LA, USA.
  • Division of Nephrology, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA.

ORCID-Profile: Jessan A Jishu

Zitieren

APA

Jishu, J. A., Bruce, D., Persons, E., Herrera, M., LaForteza, A., Bashumeel, Y. Y., Shama, M. A., Sharshir, M., & Kandil, E. (2026). Permanent Hypoparathyroidism After Total Thyroidectomy Is Associated With Chronic Kidney Disease. The American Surgeon™. https://doi.org/10.1177/00031348261471480

Vancouver

Jishu JA, Bruce D, Persons E, Herrera M, LaForteza A, Bashumeel YY, et al. Permanent Hypoparathyroidism After Total Thyroidectomy Is Associated With Chronic Kidney Disease. The American Surgeon™. 2026. doi:10.1177/00031348261471480

BibTeX
@article{Jishu2026,
  author = {Jishu, Jessan A and Bruce, Dara and Persons, Emily and Herrera, Marcela and LaForteza, Alexandra and Bashumeel, Yaser Y and Shama, Mohamed A and Sharshir, Moh'd and Kandil, Emad},
  title = {Permanent Hypoparathyroidism After Total Thyroidectomy Is Associated With Chronic Kidney Disease},
  journal = {The American Surgeon™},
  year = {2026},
  doi = {10.1177/00031348261471480}
}
Kostenlos starten →